Table 1.
Demographic data of the SR device group and the active control group.
| Total (n = 35) | Group A (n = 20) | Group B (n = 15) | P value | |
|---|---|---|---|---|
| Age, y | 62.09 ± 13.26 | 65.40 ± 11.23 | 57.67 ± 15.97 | .102 |
| Gender, male, n (%) | 29 (82.86%) | 15 (75.00%) | 14 (93.30%) | .154 |
| Weight | 64.71 ± 8.85 | 63.19 ± 8.03 | 66.73 ± 9.95 | .253 |
| Height | 166.49 ± 7.41 | 166.06 ± 7.55 | 167.07 ± 7.23 | .694 |
| BMI | 23.34 ± 2.88 | 22.96 ± 2.96 | 23.84 ± 2.77 | .379 |
| Hypertension, n (%) | 10 (28.57%) | 6 (30.00%) | 4 (26.67%) | .829 |
| Diabetes mellitus, n (%) | 7 (20.00%) | 5 (25.00%) | 2 (13.33%) | .393 |
| AUASS (baseline) | 14.89 ± 6.56 | 16.40 ± 6.27 | 12.87 ± 6.94 | .124 |
| N-QOL (baseline) | 29.6 ± 8.67 | 27.50 ± 8.74 | 32.40 ± 8.57 | .107 |
| PSQI (baseline) | 8.80 ± 4.06 | 9.45 ± 3.97 | 7.93 ± 4.17 | .281 |
| ESS (baseline) | 8.37 ± 4.31 | 9.25 ± 4.04 | 7.20 ± 4.68 | .174 |